Health Catalyst, INC 8-K filings

Health Catalyst announced the sale of its Vitalware business unit to Med-Metrix for $147 million, aiming to accelerate its strategic transformation and focus on AI and core technology.

Health Catalyst announced first quarter 2026 financial results, with revenue and adjusted EBITDA surpassing expectations, alongside a strategic operating model transformation.

Health Catalyst is reducing its global workforce by approximately 9% as part of a strategic initiative to streamline operations and focus on core technology opportunities.

Health Catalyst, a healthcare data and analytics provider, reported mixed financial results for Q4 and full year 2025, with revenue growth but significantly increased net losses and a substantial goodwill impairment.

Health Catalyst, Inc. announced that Chief Commercial Officer Kevin Freeman will transition from his role on February 1, 2026, to become a senior advisor.

Health Catalyst, Inc. announced preliminary unaudited 2025 financial results, exceeding revenue guidance and meeting Adjusted EBITDA targets, alongside strategic updates for 2026.

Health Catalyst, Inc. announced the appointment of Matt Arens, CEO of its largest shareholder First Light Asset Management, to its Board of Directors, alongside a voting and confidentiality agreement.

Health Catalyst reported third-quarter 2025 financial results, exceeding revenue and Adjusted EBITDA guidance, while reaffirming its full-year 2025 outlook despite anticipated revenue headwinds in 2026.

Health Catalyst, Inc. announces the appointment of Benjamin Albert as President and Chief Operating Officer, effective September 16, 2025, as current CEO Dan Burton plans retirement by June 2026.

Health Catalyst reported strong Q2 2025 financial results exceeding guidance, but announced CEO Dan Burton's retirement and lowered its full-year revenue outlook due to funding cuts and delays.

Health Catalyst, Inc. announced that its stockholders approved all four proposals at the Annual Meeting, including the election of two Class III directors, ratification of Ernst & Young LLP as independent auditors, approval of executive compensation, and an advisory vote to declassify the Board of Directors.

Health Catalyst announced first quarter 2025 financial results, exceeding guidance with $79.4 million in total revenue and $6.3 million in Adjusted EBITDA, and added 10 net new Platform Clients.

Health Catalyst announces positive financial results for 2024, including revenue of $307 million and Adjusted EBITDA of $26 million, and anticipates continued growth in 2025.

Health Catalyst has announced a definitive agreement to acquire Upfront Healthcare, along with preliminary 2024 financial results and forward-looking targets for 2025.

Health Catalyst reported strong Q3 2024 financial results, announced the acquisition of Intraprise Health, and appointed Dr. Jill Hoggard Green to its board of directors.

Health Catalyst reported strong Q2 2024 financial results, exceeding guidance and demonstrating significant growth in new platform subscription clients.

Health Catalyst has entered into a five-year term loan agreement for up to $225 million to refinance existing debt and support future growth initiatives.

Health Catalyst held its annual meeting on June 13, 2024, where stockholders elected three directors, ratified the appointment of Ernst & Young LLP as the independent auditor, and approved executive compensation.

Health Catalyst reported strong first-quarter 2024 financial results, surpassing the midpoint of its guidance for both revenue and Adjusted EBITDA, and reiterated its full-year outlook.

Health Catalyst reported its Q4 and full year 2023 financial results, exceeding revenue guidance but experiencing a lower than expected dollar-based retention rate, while also announcing significant leadership changes and providing financial guidance for 2024.